JMA Exec Chides Pharma for Requesting Price Measure to Ensure Stable Supplies, Says Compliance System Should Come First

Kokuto Kimori, Executive Member, Japan Medical Association (JMA) The pharmaceutical industry is calling on the government to introduce pricing measures for a designated list of “stable supply medicines” deemed to be crucial in clinical practices, but the Japan Medical Association...read more